Clive Woffendin

Title: Clive Woffendin: Innovator in HIV Research

Introduction

Clive Woffendin is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of HIV research, focusing on innovative methods for gene transfer and expression inhibition. With a total of 2 patents, his work has the potential to impact the treatment of HIV infections.

Latest Patents

Woffendin's latest patents include groundbreaking inventions aimed at combating HIV. The first patent, titled "Introduction of HIV-protective genes into cells by particle-mediated," describes a method for stably introducing foreign genes into various immune cells, including T cells and macrophages. This technique is particularly effective for treating patients infected with HIV. The second patent, "Recombinant nucleic acids for inhibiting HIV gene expression," provides recombinant nucleic acid molecules that enhance the expression of genes inhibiting HIV. Cells transfected with these molecules exhibit prolonged life, offering new avenues for treatment.

Career Highlights

Throughout his career, Clive Woffendin has worked with esteemed institutions, including the University of Michigan. His research has focused on innovative solutions to complex medical challenges, particularly in the realm of infectious diseases.

Collaborations

Woffendin has collaborated with notable professionals in the field, including Gary J Nabel and Michael J Sheehy. These partnerships have contributed to the advancement of his research and the development of his patents.

Conclusion

Clive Woffendin's contributions to HIV research through his innovative patents highlight his commitment to improving treatment options for patients. His work exemplifies the importance of research and collaboration in the fight against infectious diseases.